Cases: Reversible retiform purpura: A sign of cocaine use

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 9, 2011, Pages

  Han, Christina ^a   Sreenivasan, Gayatri ^a   Dutz, Jan P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; COCAINE; DALTEPARIN; HEMOGLOBIN; IMMUNOGLOBULIN M ANTIBODY; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; STEROID; WARFARIN; LEVAMISOLE;

ABSTINENCE; ADULT; ANTIBODY TITER; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; COCAINE USE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HOSPITAL READMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; NEUTROPENIA; NEUTROPHIL COUNT; PURPURA; RETIFORM PURPURA; SKIN BIOPSY; SKIN NECROSIS; SKIN ULCER; SUBSTANCE ABUSE; VASCULAR DISEASE; VASCULAR NECROSIS; COCAINE DEPENDENCE; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; PATHOLOGY; SKIN BLOOD VESSEL DISORDER;

COCAINE-RELATED DISORDERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEVAMISOLE; MIDDLE AGED; PURPURA; SKIN DISEASES, VASCULAR;

EID: 79958228764     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.101005     Document Type: Article

References (19)

1. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. 2nd ed. Spain: Mosby; 2008. p. 323.
2. Bradford M, Rosenberg B, Moreno J, et al. Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 2010;152:758-9.
3. Waller JM, Feramisco JD, Alberta-Wszolek L, et al. Cocaine-associated retiform purpura and neutropenia: Is levamisole the culprit? [letter] J Am Acad Dermatol 2010;63:530-5.
4. Buchanan JA, Vogel JA, Eberhardt AM. Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole. J Med Toxicol 2010 June 12 [Epub ahead of print].
5. Rongioletti F, Ghio L, Ginevri F, et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 1999;140:948-51. (Pubitemid 29238474)
6. Menni S, Pistritto G, Gianotti R, et al. Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient. Pediatr Dermatol 1997;14:477-9. (Pubitemid 28012032)
7. Walsh NM, Green PJ, Burlingame RW, et al. Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol 2010;37:1212-9.
8. National drug threat drug assessment 2010. Washington (DC): US Department of Justice, National Drug Intelligence Center; 2010. Available: www.justice.gov/ndic/pubs38/38661/drugImpact.htm (accessed 2010 June 19).
9. Wiens MO, Son WK, Ross C, et al. Cocaine adulterant linked to neutropenia. CMAJ 2010;182:57-9.
10. Gulati OD, Hemavathi KG, Joshi DP. Interactions of levamisole with some autonomic drugs on guinea-pig vas deferens. J Auton Pharmacol 1985;5:19-23. (Pubitemid 15117228)
11. Czuchlewski DR, Brackney M, Ewers C, et al. Clinicopathologic features of agranulocytosis in the setting of levamisoletainted cocaine. Am J Clin Pathol 2010;133:466-72.
12. Zhu NY, LeGatt DF, Turner AR. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 2009;150:287-9.
13. Bagga A, Hari P. Levamisole-induced vasculitis. Pediatr Nephrol 2000;14:1057-8. (Pubitemid 30621326)
14. Ferlazzo B, Barresi G, Puglisi A. Cutaneous necrotizing vasculitis caused by immunocomplexes during treatment with levamisole [article in Italian]. Boll Ist Sieroter Milan 1983;62:107-11. (Pubitemid 14229156)
15. Laux-End R, Inaebnit D, Gerber HA, et al. Vasculitis associated with levamisole and circulating autoantibodies. Arch Dis Child 1996;75:355-6. (Pubitemid 26354616)
16. Macfarlane DG, Bacon PA. Levamisole-induced vasculitis due to circulating immune complexes. BMJ 1978;1:407-8. (Pubitemid 8318798)
17. Scheinberg MA, Bezerra JB, Almeida FA, et al. Cutaneous necrotising vasculitis induced by levamisole. BMJ 1978;1:408. (Pubitemid 8318799)
18. Drew SI, Carter BM. Granulocytotoxic autoantibodies in HLA-B27 neutropenic patients. Transplantation 1979;27:436-7. (Pubitemid 9200723)
19. Kouassi E, Caille G, Lery L, et al. Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos 1986;7:71-89. (Pubitemid 16155186)